With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
The validations confirm the completion of the applications and commence the scientific review process
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Oteseconazole Capsules were found to be safe and more effective than fluconazole
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Subscribe To Our Newsletter & Stay Updated
